Ambu - Revenio of Endoscopic Devices

However, even this company made its biggest profit ever in 2025 (it probably increased by about 2.5 times from 2024), and revenue is growing very predictably (year after year). I think the decline experienced in the stock is just a correction of the high valuation of previous years. The P/E ratio, however, used to hover around 200-300 for a long time. Now it has come down to more reasonable levels. Below is the P/E ratio history from Tradingeconomics.

2 Likes